It is available through licensed compounding pharmacies in the current regulatory environment and is used off-label under physician supervision
We are committed to protecting your privacy and do not share any customer data with third parties
Zepbound (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
DSIP Epithalon:
When you have anemia, your body has a hard time getting enough oxygen to your tissues, which can lead to weakness and other complications
Chang, C., Tsai, W., Lin, M., Hsu, Y., & Pang, J